Postpartum depression (PPD) is common, disabling, and treatable. The strongest risk factor
is a history of mood or anxiety disorder, especially having active symptoms during …

Abstract Purpose of Review We give an overview of recent developments on psychological
treatments of depression in primary care. Recent Findings In recent years, it has become …

Objectives: To provide advice and guidance regarding the management of mood disorders,
derived from scientific evidence and supplemented by expert clinical consensus to formulate …

Postpartum depression is common; however, little is known about its relationship to social
support and postpartum depression. This study examined the association between them …

Background The association of breastfeeding (BF) for postpartum depression (PPD) remains
controversial. Currently there are no specific guidelines on the role of BF in the management …

Background Depression during pregnancy and after the birth of a child is highly prevalent
and an important public health problem. Psychological interventions are the first-line …

Introduction Postpartum depression (PPD) is a serious maternal disorder that can have
adverse effects on maternal and infant health. The importance of offering effective and …

In March, 2019, the US Food and Drug Administration (FDA) approved two new
antidepressants: esketamine for treatment-resistant depression1 and brexanolone for …

The present study evaluated the combined effectiveness of cognitive behavioral therapy
(CBT) for postnatal depression. A systematic search was conducted across databases …

Abstract Purpose of Review Mental and physical disorders commonly co-occur leading to
higher morbidity and mortality in people with mental and substance use disorders …